Open AccessAcute Lymphoblastic Leukemia as Secondary Malignancy in a Case of Ewing’s Sarcoma on Treatment
Author(s) -
Satyam Satyarth,
Sonia Parikh,
Asha Anand,
Jyoti Sawhney,
Harsha Panchal,
Apurva Patel,
Sonal Patel Shah
Publication year - 2017
Publication title -
indian journal of medical and paediatric oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.229
H-Index - 22
eISSN - 0975-2129
pISSN - 0971-5851
DOI - 10.4103/ijmpo.ijmpo_110_16
Subject(s) - medicine , lymphoblastic leukemia , sarcoma , malignancy , leukemia , myeloid leukemia , refractory (planetary science) , oncology , pathology , physics , astrobiology
The survival of Ewing's sarcoma (ES) has improved due to advances in both local and systemic therapy. This has given rise to an increased detection of second malignant neoplasms which can be in the form of solid tumors and hematological malignancies. The most common hematological malignancies are acute myeloid leukemia/myelodysplastic syndrome. Acute lymphoblastic leukemia (ALL) is relatively uncommon in occurrence in this setting. Furthermore, the average refractory period for hematological malignancies varies from 3 to 5 years. We report a case of a young female who developed ALL while on adjuvant therapy for ES.